CUSIP: 03852X100
Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,987,020
-
Share change
-
+871,106
-
Total reported value
-
$127,844,265
-
Put/Call ratio
-
116%
-
Price per share
-
$4.41
-
Number of holders
-
75
-
Value change
-
+$3,315,458
-
Number of buys
-
37
-
Number of sells
-
28
Quarterly Holders Quick Answers
What is CUSIP 03852X100?
CUSIP 03852X100 identifies ARLZ - ARALEZ PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Institutional Holders of ARALEZ PHARMACEUTICALS INC - COM (ARLZ) as of Q4 2016
As of 31 Dec 2016,
ARALEZ PHARMACEUTICALS INC - COM (ARLZ) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,987,020 shares.
The largest 10 holders included
PAR CAPITAL MANAGEMENT INC, Broadfin Capital, LLC, ARMISTICE CAPITAL, LLC, JW Asset Management, LLC, Elk Creek Partners, LLC, Tiger Legatus Capital Management, LLC, DEERFIELD MANAGEMENT CO, BlackRock Fund Advisors, Healthcare Value Capital, LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
75
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.